Woo Y, Ma M, Okawa M, Saito T
Viruses. 2024; 16(5).
PMID: 38793622
PMC: 11126147.
DOI: 10.3390/v16050740.
Ge F, Yang Y, Bai Z, Si L, Wang X, Yu J
Chin Med. 2023; 18(1):159.
PMID: 38042824
PMC: 10693092.
DOI: 10.1186/s13020-023-00861-2.
Guo H, Urban S, Wang W
Front Microbiol. 2023; 14:1169770.
PMID: 37089540
PMC: 10113554.
DOI: 10.3389/fmicb.2023.1169770.
Yan H, Wang C
Viruses. 2023; 15(2).
PMID: 36851726
PMC: 9959848.
DOI: 10.3390/v15020512.
Majeed N, Hitawala A, Heller T, Koh C
Liver Int. 2023; 43 Suppl 1:31-46.
PMID: 36621853
PMC: 10329733.
DOI: 10.1111/liv.15515.
HepG2-NTCP Subclones Exhibiting High Susceptibility to Hepatitis B Virus Infection.
Zahoor M, Kuipery A, Mosa A, Gehring A, Feld J
Viruses. 2022; 14(8).
PMID: 36016422
PMC: 9412438.
DOI: 10.3390/v14081800.
Novel Therapies of Hepatitis B and D.
Khan I, Dad Ullah M, Choudhry M, Ali M, Ali M, Lam S
Microorganisms. 2021; 9(12).
PMID: 34946209
PMC: 8707465.
DOI: 10.3390/microorganisms9122607.
Mutational Analysis of the GXXXG/A Motifs in the Human Na/Taurocholate Co-Transporting Polypeptide NTCP on Its Bile Acid Transport Function and Hepatitis B/D Virus Receptor Function.
Palatini M, Muller S, Lowjaga K, Noppes S, Alber J, Lehmann F
Front Mol Biosci. 2021; 8:699443.
PMID: 34239896
PMC: 8257933.
DOI: 10.3389/fmolb.2021.699443.
A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process.
Perez-Vargas J, Teppa E, Amirache F, Boson B, Pereira de Oliveira R, Combet C
Elife. 2021; 10.
PMID: 34190687
PMC: 8282342.
DOI: 10.7554/eLife.64507.
NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population.
Nyarko E, Obirikorang C, Owiredu W, Adu E, Acheampong E, Aidoo F
Virol J. 2020; 17(1):91.
PMID: 32620148
PMC: 7333392.
DOI: 10.1186/s12985-020-01376-0.
An update on the management of chronic hepatitis D.
Shah P, Choudhry S, Reyes K, Lau D
Gastroenterol Rep (Oxf). 2020; 7(6):396-402.
PMID: 32494363
PMC: 7249531.
DOI: 10.1093/gastro/goz052.
In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.
Wose Kinge C, Bhoola N, Kramvis A
Viruses. 2020; 12(3).
PMID: 32210021
PMC: 7150782.
DOI: 10.3390/v12030353.
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.
Nguyen M, Wong G, Gane E, Kao J, Dusheiko G
Clin Microbiol Rev. 2020; 33(2).
PMID: 32102898
PMC: 7048015.
DOI: 10.1128/CMR.00046-19.
Drugs in Development for Hepatitis B.
Dawood A, Abdul Basit S, Jayaraj M, Gish R
Drugs. 2017; 77(12):1263-1280.
PMID: 28660478
PMC: 5529495.
DOI: 10.1007/s40265-017-0769-2.
Hepatitis B virus molecular biology and pathogenesis.
Lamontagne R, Bagga S, Bouchard M
Hepatoma Res. 2017; 2:163-186.
PMID: 28042609
PMC: 5198785.
DOI: 10.20517/2394-5079.2016.05.
The current status and future directions of hepatitis B antiviral drug discovery.
Tang L, Zhao Q, Wu S, Cheng J, Chang J, Guo J
Expert Opin Drug Discov. 2016; 12(1):5-15.
PMID: 27797587
PMC: 5444906.
DOI: 10.1080/17460441.2017.1255195.
Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
He W, Cao Z, Mao F, Ren B, Li Y, Li D
J Virol. 2016; 90(19):8866-74.
PMID: 27466423
PMC: 5021397.
DOI: 10.1128/JVI.00901-16.
Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.
Zou J, Cao Z, Zhang J, Chen T, Yang S, Huang Y
Oncotarget. 2016; 7(26):40135-40147.
PMID: 27223085
PMC: 5129998.
DOI: 10.18632/oncotarget.9510.
Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.
Li W, Urban S
J Hepatol. 2016; 64(1 Suppl):S32-S40.
PMID: 27084034
PMC: 7114860.
DOI: 10.1016/j.jhep.2016.02.011.
Experimental models of hepatitis B and C - new insights and progress.
Thomas E, Liang T
Nat Rev Gastroenterol Hepatol. 2016; 13(6):362-74.
PMID: 27075261
PMC: 5578419.
DOI: 10.1038/nrgastro.2016.37.